SCOTTSDALE, AZ--(Marketwire - June 14, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI), the makers of ProAlgaZyme, announced today they will be exhibiting and introducing ProAlgaZyme to prospective new retailers from all over the world at the 70th Annual Natural Products Trade Show and Convention, July 20-22. The Company will use the event as the kick-off for the national distribution of ProAlgaZyme, building on the recent signing of three distributor agreements based in the south, northeast, and southwest of the United States. Two other distributor agreements are under negotiation.

Information from test marketing of ProAlgaZyme in the Company's home market of Phoenix, Arizona will be used in the national roll-out. Optimized packaging and presentation of ProAlgaZyme have been implemented at the Company's production facility. Also, HEPI's new automated bottling line in Scottsdale, Arizona has been upgraded to ensure the ability to handle potential new business.

The Natural Product Trade Show and Convention is attended by over 7,500 buyers from major natural health retailers around the world. The demographics of qualified buyers are unsurpassed in the natural food products market. Attending and staffing the Company's booth, which will be next to the main entrance, will be CEO Tom Ingolia and Director of Sales John Gorman.

About the Natural Products Association

The Natural Products Association (formerly NNFA) is the leading trade association for the natural products industry, protecting and promoting the business of health for both suppliers and retailers. Each year, the natural products community turns to the Natural Products Association's convention and trade show to discover health and nutrition trends, scientific advancements, new products and business innovations -- connecting natural product suppliers and buyers on the cutting-edge of the industry.

About Health Enhancement Products, Inc. and ProAlgaZyme

Health Enhancement Products, Inc. is a nutraceutical company engaged in the development of a Dietary Supplement product using only pure, all-natural ingredients. The Company's sole product is ProAlgaZyme, a liquid product produced from algae grown in 100% distilled water. The liquid in which the algae are grown is drawn off, filtered, tested and bottled as ProAlgaZyme.

Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, our inability to obtain regulatory approvals necessary to market and sell PAZ as a pharmaceutical, and the company's ability to secure funding, including for the subsidiary's pharmaceutical development of PAZ. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.

For more information, please visit

Contact Information: Contact information: Thomas D. Ingolia CEO Email Contact: 480-385-3800